Skip to main content

Perspectives

Cancer Care in 2013: Hope, Reality, and a Call to Action

Gary M. Owens, MD

Specialty Pharmaceuticals Update

David B. Nash, MD, MBA

Implications of the Employer Mandate Delay on the Healthcare Marketplace

Kip Piper, MA, FACHE, F. Randy Vogenberg, PhD, FASHP

Increasing Importance of Oncology Drug Management for Payers

James T. Kenney, RPh, MBA

The Changing Face of Cancer Care: Evolution to a Collaborative Model

Michael Kolodziej, MD, FACP

Reflections on Japan’s Complex Medical Culture

David B. Nash, MD, MBA

Analyzing the Medtech Industry: A Predictive Tool in Healthcare

David B. Nash, MD, MBA

New Data Presented at Highlight Challenges and Opportunities for Payers

Matthew Mitchell, PharmD, MBA, FAMCP

Perspectives, Technology

Technology Trends in Healthcare

David B. Nash, MD, MBA

Interesting Times Ahead: Payers’ Innovation in the Era of Healthcare Reform

Albert Tzeel, MD, MHSA, CPE, FAAPL

Page 12 of 18
Results 111 - 120 of 173